Updated Findings from bluebird bio
- bluebird bio analyses demonstrate lentiviral vector BB305 unlikely to be the cause of AML in a clinical study of LentiGlobin for SCD
- bluebird bio initiated a process with regulators to resume clinical studies
bluebird bio (BLUE)
This content is for paid subscribers.
Today’s Highlights March 10, 2021